178 related articles for article (PubMed ID: 32332845)
21. MiR-940 promotes malignant progression of breast cancer by regulating FOXO3.
Zhang H; Peng J; Lai J; Liu H; Zhang Z; Li X; Liang B; Chen X; Zou B; Lin S; Zhang L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32840296
[TBL] [Abstract][Full Text] [Related]
22. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
[TBL] [Abstract][Full Text] [Related]
23. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway.
Huang Y; Fan X; Tao R; Song Q; Wang L; Zhang H; Kong H; Huang J
J Cell Physiol; 2018 Oct; 233(10):6693-6704. PubMed ID: 29323718
[TBL] [Abstract][Full Text] [Related]
24. FOXO1-dependent DNA damage repair is regulated by JNK in lung cancer cells.
Ju Y; Xu T; Zhang H; Yu A
Int J Oncol; 2014 Apr; 44(4):1284-92. PubMed ID: 24452601
[TBL] [Abstract][Full Text] [Related]
25. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
26. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
Zhao Z; Li C; Xi H; Gao Y; Xu D
Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
[TBL] [Abstract][Full Text] [Related]
27. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
Lian R; Lu B; Jiao L; Li S; Wang H; Miao W; Yu W
Eur J Pharmacol; 2016 Dec; 792():1-6. PubMed ID: 27751825
[TBL] [Abstract][Full Text] [Related]
28. Multifaceted functions of the forkhead box transcription factors FoxO1 and FoxO3 in skin.
Tsitsipatis D; Klotz LO; Steinbrenner H
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1057-1064. PubMed ID: 28249743
[TBL] [Abstract][Full Text] [Related]
29. CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification.
Jie M; Wu Y; Gao M; Li X; Liu C; Ouyang Q; Tang Q; Shan C; Lv Y; Zhang K; Dai Q; Chen Y; Zeng S; Li C; Wang L; He F; Hu C; Yang S
Mol Cancer; 2020 Mar; 19(1):56. PubMed ID: 32164722
[TBL] [Abstract][Full Text] [Related]
30. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
31. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
[TBL] [Abstract][Full Text] [Related]
32. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
Qi W; Weber CR; Wasland K; Savkovic SD
BMC Cancer; 2011 Jun; 11():219. PubMed ID: 21639915
[TBL] [Abstract][Full Text] [Related]
33. FoxO1 enhances differentiation and apoptosis in human primary keratinocytes.
Shi G; Liao PY; Cai XL; Pi XX; Zhang MF; Li SJ; Quan JH; Fan YM
Exp Dermatol; 2018 Nov; 27(11):1254-1260. PubMed ID: 30144329
[TBL] [Abstract][Full Text] [Related]
34. Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.
Wu WR; Lin JT; Pan CT; Chan TC; Liu CL; Wu WJ; Sheu JJ; Yeh BW; Huang SK; Jhung JY; Hsiao MS; Li CF; Shiue YL
Theranostics; 2020; 10(2):707-724. PubMed ID: 31903146
[TBL] [Abstract][Full Text] [Related]
35. mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity.
Jimenez L; Amenabar C; Mayoral-Varo V; Mackenzie TA; Ramos MC; Silva A; Calissi G; Grenho I; Blanco-Aparicio C; Pastor J; Megías D; Ferreira BI; Link W
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080182
[TBL] [Abstract][Full Text] [Related]
36. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
[TBL] [Abstract][Full Text] [Related]
37. FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide.
Weidinger C; Krause K; Mueller K; Klagge A; Fuhrer D
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1361-71. PubMed ID: 21752881
[TBL] [Abstract][Full Text] [Related]
38. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
Liu MK; Ma T; Yu Y; Suo Y; Li K; Song SC; Zhang W
Technol Cancer Res Treat; 2019; 18():1533033819886897. PubMed ID: 31714185
[TBL] [Abstract][Full Text] [Related]
39. KRAS gene silencing inhibits the activation of PI3K-Akt-mTOR signaling pathway to regulate breast cancer cell epithelial-mesenchymal transition, proliferation and apoptosis.
Zhang Y; Liu JL; Wang J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3085-3096. PubMed ID: 32271426
[TBL] [Abstract][Full Text] [Related]
40. The regulation of FOXO1 and its role in disease progression.
Xing YQ; Li A; Yang Y; Li XX; Zhang LN; Guo HC
Life Sci; 2018 Jan; 193():124-131. PubMed ID: 29158051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]